SCTX ▲ +6.3% - Scribe Therapeutics Inc. $SCTX - Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Scribe Therapeutics rose 6.3% following the release of its second quarter 2026 financial results and corporate highlights. The stock's gain suggests investors responded positively to the company's operational updates or financial performance disclosed in the earnings report. 02-SEP-2026 04:08 PM ET